PT - JOURNAL ARTICLE AU - Yong Li AU - Shuzheng Lyu TI - Development and external validation of a diagnostic model for periprocedural bradycardia during primary percutaneous coronary intervention AID - 10.1101/2020.06.26.20140558 DP - 2020 Jan 01 TA - medRxiv PG - 2020.06.26.20140558 4099 - http://medrxiv.org/content/early/2020/06/29/2020.06.26.20140558.short 4100 - http://medrxiv.org/content/early/2020/06/29/2020.06.26.20140558.full AB - Background Periprocedural bradycardia weaks the benefit of primary percutaneous coronary intervention (PPCI) and has deleterious effects on organ perfusion of patients with acute ST elevation myocardial infarction (STEMI).Objective To develop and externally validate a diagnostic model of periprocedural bradycardia..Methods Design: Multivariable logistic regression of a cohort of acute STEMI patients. Setting: Emergency department ward of a university hospital. Participants: Diagnostic model development: Totally 1820 acute STEMI patients who were consecutively treated with PPCI from November 2007 to December 2015 in Beijing Anzhen Hospital, Capital Medical University. External validation: Totally 716 acute STEMI patients who were treated with PPCI from January 2016 to June 2018 in Beijing Anzhen Hospital, Capital Medical University. Outcomes:Periprocedural bradycardia during PPCI. Periprocedural bradycardia was defined as preoperative heart rate ≥ 50 times / min, intraoperative heart rate <50 times / min persistent or transient.Results Totally 332 (18.2%)patients presented periprocedural bradycardia in the development dataset and 102 (14.2%) patients presented periprocedural bradycardia in the validation dataset. The strongest predictors of periprocedural bradycardia were intra-procedural hypotension, the culprit vessel was not left anterior descending (LAD), using thrombus aspiration devices during procedure, sex, history of coronary artery disease, total occlusion of culprit vessel, and no-reflow. We developed a diagnostic model of periprocedural bradycardia.The area under the receiver operating characteristic(ROC) curve(AUC) was 0.8384± 0.0122 in the development set. We constructed a nomogram based on predictors of periprocedural bradycardia using the development database. The AUC was 0.8437±0.0203 in the validation set. Discrimination, calibration, and decision curve analysis were satisfactory.Conclusions We developed and externally validated a diagnostic model of periprocedural bradycardia during PPCI.We registered this study with WHO International Clinical Trials Registry Platform(ICTRP). Registration number: ChiCTR1900023214.Registered Date :16 May 2019. http://www.chictr.org.cn/edit.aspx?pid=39087&htm=4Competing Interest StatementThe authors have declared no competing interest.Clinical TrialChiCTR1900023214Funding StatementNone.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by ethic committee.Approved No. of ethic committee: 2019012X. Name of the ethic committee:Ethics committee of Beijing anzhen hospital capital medical university. It was a retrospective analysis and informed consent was waived by Ethics Committee of Beijing Anzhen Hospital Capital Medical University. All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data used to support the findings of this study are included within the supplementary information file(s). Code availability (software application or custom code) The data was demographic, clinical, and angiographic of patients with acute STEMI. AGE=age; CADH=history of corony artery disease; CNR=no-reflow; HD= history of diabetes; HH = history of hypertension; IH=intra-procedural hypotension; LAD=the culprit vessel was left anterior descending; LCX=the culprit vessel was left circumflex coronary artery; PB=periprocedural bradycardia; RCA= the culprit vessel was right coronary artery; S= sex; TA= using thrombus aspiration devices during procedure. https://pan.baidu.com/s/1rtdC2HIiCXJ_e25d20OO7A AICAkaike information criterionAMIacute myocardial infarctionAUCarea under the receiver operating characteristic (ROC) curveBICBayesian information criterionCIconfidence intervalDCAcalibration and decision curve analysisLADleft anterior descendingLCXleft circumflex coronary arteryPPCIprimary percutaneous coronary interventionRCAright coronary arteryROCreceiver operating characteristicSTEMIST elevation myocardial infarctionTIMIThrombolysis In Myocardial Infarction flow gradeTRIPODTransparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis